Co-Diagnostics, Inc. — Form 8-K
Filed September 4, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 28/100
What the filing says
Co-Diagnostics filed an 8-K on 2026-09-04 reporting Item 5.02 events (departure/appointment of directors or officers; compensatory arrangements). The filing document itself does not contain the specific names, dollar amounts, dates of changes, or nature of arrangements—only that such changes occurred. No counterparties, compensation figures, share counts, or concrete details are provided in the accessible filing metadata.
Why this rating
No material specifics disclosed in available text. Leadership/compensation changes are routine at small $10M market-cap firms; significance indeterminate without actual terms.
Extracted items
See more from September 4, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.